What is Kura Oncology's net change in cash?

Kura Oncology (KURA) reported net change in cash of -$110.02M in Q1 2026.

How has Kura Oncology's net change in cash changed year-over-year?

Kura Oncology's net change in cash increased by 36.5% year-over-year, from -$173.19M to -$110.02M.

What does net change in cash mean?

Total increase or decrease in cash during the period — the sum of operating, investing, financing cash flows plus FX effects.

Kura Oncology KURA Net Change in Cash

Net Change in Cash at other companies

Johnson & JohnsonJNJ

$1.98B-86.2%

AmgenAMGN

$2.91B+192%

ExelixisEXEL

-$256.34M-662%

Syndax PharmaceuticalsSNDX

-$4.04M-4,386%

AbbVieABBV

$4.16B+1,293%

Corvus PharmaceuticalsCRVS

$35.53M+1,050%

Other financials

Income statement

See full

Revenue$18.3M+29.5%

Gross profit$18.0M—

Operating income-$78.8M-21.8%

Net income-$73.3M-27.7%

EPS (diluted)-$0.83-25.8%

Balance sheet

See full

Cash & equivalents$39.1M-23.8%

Total debt$24.3M+25.4%

Total equity$107.9M-70.4%

Total assets$652.6M-12.3%

Cash flow

See full

Operating cash flow-$85.9M-19.4%

CapEx$128.0K-56.2%

Free cash flow-$86.0M-19.1%

Valuation

See full

Market cap$919.7M+81.6%

Enterprise value$904.89M+90.7%

P/S12.8×+3.5×

Profitability

See full

Operating margin-443.5%+103pp

Net margin-411.2%+125pp

FCF margin130.6%+74.1pp

Returns & leverage

See full

Return on equity-124.7%-252pp

Debt / equity0.2×+0.2×

Current ratio6.1×-1.9×

Where this comes from

Reported directly by Kura Oncology in its filing.

Tagged under the XBRL concept us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect.

The official record: Kura Oncology’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about Kura Oncology's net change in cash.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Kura Oncology's net change in cash?: Kura Oncology (KURA) reported net change in cash of -$110.02M in Q1 2026.
How has Kura Oncology's net change in cash changed year-over-year?: Kura Oncology's net change in cash increased by 36.5% year-over-year, from -$173.19M to -$110.02M.
What does net change in cash mean?: Total increase or decrease in cash during the period — the sum of operating, investing, financing cash flows plus FX effects.